# Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants

> **NCT07409922** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jiangxi Kvvit Pharmaceutical Co., Ltd.** · enrollment: 92 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** KR23343
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT07409922
- **Lead sponsor:** Jiangxi Kvvit Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-03
- **Primary completion:** 2026-11-20
- **Final completion:** 2026-11-20
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07409922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07409922, "Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07409922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*